Vexim
FranceWho owns Vexim?
Vexim is a French MedTech company, now owned by Stryker, which acquired it in 2018 from Truffle Capital.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2018 to Stryker.
- ·Best return: 2.0x MOIC by M Capital (2017 exit).
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
M Capital sold Vexim to Stryker in 2017 after 3 years.
Truffle Capital sold VEXIM to Stryker in 2018 after 2 years.
More from Truffle BioMedTech
Other portfolio companies in the same fund.
USMore PE-backed in MedTech
Comparable medtech deals from other GPs.
GermanyQuestions
Who owns Vexim?
Vexim is now owned by Stryker, which acquired it in 2018 from Truffle Capital.
When did Stryker acquire Vexim?
Stryker acquired Vexim in 2018, buying from Truffle Capital.
Who did Vexim sell to?
Truffle Capital sold Vexim to Stryker in 2018 (Trade Sale). M Capital sold Vexim to Stryker in 2017 (Trade Sale), 2.0x return.
Who has owned Vexim over time?
Vexim has been through 2 private-equity ownership periods: M Capital · via M Capital Capital Développement · 2014–2017 · sold to Stryker · (Trade Sale) · 2.0x; Truffle Capital · via Truffle BioMedTech · 2016–2018 · sold to Stryker · (Trade Sale).